Drugs (Administered) · J7612 · Drug

Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg

What Medicare pays for J7612, what providers bill, and how the price varies across 10 states, drawn from CMS 2023 claims data.

$0.17
Medicare pays
$4.03
Providers bill
23.1×
Markup
#4,982 of 9,297
Volume rank

The verdict

Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg posts modest national service volume.

46th pct.
national service volume
$0.17
Medicare pays, national avg

Volume percentile ranks this code's national service volume against every tracked procedure; markup percentile ranks its billed-to-Medicare ratio the same way. The same two figures drive both the verdict sentence and the chips above.

According to the Centers for Medicare & Medicaid Services (CMS), the 2023 Medicare Physician & Other Practitioners dataset records payments for 9,297 procedure codes billed across 5,426 hospitals in 56 states and territories; see our methodology for how each figure is sourced and computed.

View my watchlist RSS updates for this procedure
Payment tier in Drugs (Administered)
Lower-paying in category
#497 of 530 procedures in Drugs (Administered) by national average Medicare payment.
Markup tier vs. tracked procedures
23.1x markup
23.1x the Medicare rate. This procedure has too little volume for a reliable catalog-wide rank.
1.0K
Total Services
519
Beneficiaries
175
Providers
10
States with Data

Price Range Across States

Lowest State Avg
$0.15
Missouri
Highest State Avg
$0.19
Washington

What You Might Pay

Est. Commercial Insurance
$0.52
Range: $0.37 – $0.73
Est. Cash / Self-Pay
$1.28
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

How we estimate these prices

These estimates are based on the RAND Hospital Price Transparency Study (4th Edition, 2024). We map each PlainProcedure category onto a RAND CPT-section bucket (Surgery, Radiology, Pathology and Laboratory, Medicine, Anesthesia, Evaluation and Management) or fall back to the national average when no bucket matches. For Drugs (Administered), the applied ratio is 2.24x Medicare (RAND 2024 national average (2.24x); no matching CPT-section bucket for this category + CMS Medicare baseline). Cash/self-pay estimates blend typical cash discounts (55% of billed charges) with Medicare-based estimates (150% of allowed amounts). These are statistical estimates, not quotes. Contact your insurer or provider for actual costs.

Prices by State

State Medicare Payment Billed Charge
Washington $0.19 $1.85
California $0.19 $8.84
New York $0.19 $4.18
Arkansas $0.19 $1.27
Oklahoma $0.19 $6.68
Texas $0.18 $7.32
Florida $0.17 $0.81
Arizona $0.16 $2.81
Georgia $0.16 $4.08
Missouri $0.15 $7.61

What the Data Says About Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg

Across 10 states with reporting providers, CPT code J7612 (Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg) shows a national average Medicare payment of $0.17 against an average billed charge of $4.03. That gap, a 23.1x markup, or 2211% above the Medicare allowed amount, is not a meaningful ratio for this low-payment code, so treat the billed figure as a chargemaster reference point rather than a real-world price.

Drugs (Administered) procedures like this one saw 1.0K services billed to Medicare in 2023 by 175 distinct providers, serving 519 unique beneficiaries. State-level variation is significant: Missouri reports the lowest average payment at $0.15, while Washington reports the highest at $0.19. The 28% spread here is a moderate, fairly ordinary GPCI effect, local cost-of-practice adjustments nudging the allowed amount up or down without reshaping it. Applying the RAND 2024 commercial-to-Medicare ratio for this category (2.24x Medicare; RAND 2024 national average (2.24x); no matching CPT-section bucket for this category + CMS Medicare baseline), the estimated commercial insurance price lands near $0.52, with self-pay cash discounts commonly bringing the figure closer to $1.28. Within Drugs (Administered), Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg ranks #497 of 530 tracked procedures by national average Medicare payment.

Where this sits in the registry

Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg (J7612) is a CMS 2023 Part B code. These pages keep the volume map and the markup map separate.

  • National volume versus markup on the statistics page, the same two maps as this capsule. Statistics
  • Other Drugs (Administered) codes, ranked by Medicare payment inside the category. Category
  • How volume rank and markup rank are computed. Methodology
  • The full procedures listing in volume order. Procedures

Figures here are CMS averages, not a quote for any patient, plan, or visit.

Frequently Asked Questions

Where does Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg rank among Medicare procedures?

According to CMS Medicare Part B claims, Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg (CPT J7612) ranks #4,982 of 9,297 procedures by national service volume, the same sort as the procedures listing, and #497 of 530 within Drugs (Administered) by national average Medicare payment. See /methodology#corpus-placement.

How much does Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg cost?

Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg (CPT J7612) is priced fairly consistently nationwide: Medicare pays $0.17 on average, and the $0.15-$0.19 state range stays relatively tight. Providers typically bill $4.03.

Why do providers charge more than Medicare pays?

Providers set their own chargemaster rates (billed charges), which are typically much higher than what any insurer pays. Medicare pays a fixed rate based on the procedure code and geographic location. The billed charge is relevant mainly for uninsured patients, who may face prices closer to the submitted charge.

How much does Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg cost with insurance?

With commercial insurance, levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg costs an estimated $0.52 on average (range: $0.37-$0.73), a moderate premium over Medicare's $0.17. Without insurance, the estimated cash price is $1.28.

Which state has the lowest cost for Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg?

Missouri and Washington bookend the range for Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg, at $0.15 and $0.19 respectively - a relatively tight $0.04 spread nationwide.

How many providers perform Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg?

Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg is comparatively uncommon: only 175 providers nationally billed Medicare for it in 2023, serving 519 beneficiaries via 1.0K total services.

What is the billed-to-Medicare markup for Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg?

Providers bill 23.1x what Medicare pays for Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg - a markup within the typical range at 2211% above the Medicare rate.

Nationwide similar CPT codes

Data-derived peers across the CMS Physician & Other Practitioners extract: nearest national service volume and nearest average Medicare payment. Not clinical substitutes: claim-mass and payment neighborhoods only.

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure

Every figure on PlainProcedure is rendered directly from CMS Medicare Physician & Other Practitioners data, no number is typed in by an editor. This page draws directly on CMS Medicare Physician & Other Practitioners data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.